Loading the section
The price of Progyny, Inc. (PGNY) on October 9, 2026 is 27.93 USD, +0.36% on the day. Over 52 weeks the stock traded between 16.10 USD and 33.06 USD; the price now sits 70% of the way up that range. Over the past year the price changed by +35.71%. The P/E ratio is 32.0, which is above the sector median (24.8). Market capitalization is 2.17 billion USD, rank 3 among 8 stocks of the same industry with a known capitalization.
Closing prices for 09 October 2026
Next earnings report: none scheduled in the next five weeks · Earnings calendar
Progyny, Inc. trades on Nasdaq under the ticker PGNY. The company belongs to the Health care sector. The trading history on this page starts on 25 October 2019.
Over the past 52 weeks PGNY has traded between 16.10 $ and 33.07 $. As of 09 October 2026 the price stood 69.73 % of the way from the 52-week low to the high.
Over one year PGNY shares rose 35.71 %; over six months they rose 71.35 %. Volatility over 90 days is 33.19 %. Dividends are not included: this is price change only, as of 09 October 2026.
PGNY trades at a price-to-earnings ratio of 32.0, above the sector median of 24.8. Price to sales is 1.7, below the sector median of 3.9. Price to book is 4.9, above the sector median of 2.4. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 09 October 2026 | 27.71 | 28.24 | 27.64 | 27.93 | 694,541 |
| 08 October 2026 | 27.51 | 28.00 | 26.85 | 27.83 | 2M |
| 07 October 2026 | 25.81 | 28.32 | 25.81 | 27.55 | 2M |
| 06 October 2026 | 25.86 | 26.24 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Progyny, Inc. (PGNY) is a public company in the healthcare sector. Its common stock trade on NASDAQ.
Over the trailing twelve months as reported to 2026-03-31, revenue was 1.3bn $, net income was 67.7m $. Incorporated in US.
This summary is compiled automatically from SEC filings and exchange data.
Address:1359 BROADWAY 2ND FLOOR, NEW YORK, NY, 10018, US
Progyny, Inc. reported revenue of 1.3B $ and net income of 68M $ over the last four quarters. Net margin is 5.23 %. Revenue changed by +6.59 % year over year. Earnings per share are 0.77 $. Market capitalisation is 2.2B $.
PGNY has a return on equity of 15.41 %, above the sector median of −41.68 %. Return on assets is 9.69 %, above the sector median of −32.11 %. Operating margin is 7.46 %, above the sector median of −26.84 %.
| 8M |
| VMDViemed Healthcare, Inc. | 9.52 | +1.17 % | 2M |
| MGRXMangoceuticals, Inc. | 0.4220 | −2.31 % | 249,358 |
| BRTXBioRestorative Therapies, Inc. | 1.86 | −1.59 % | 100,407 |
| CCELCryo-Cell International, Inc. | 4.36 | +4.56 % | 56,385 |
| 25.56 |
| 25.91 |
| 868,300 |
| 05 October 2026 | 25.25 | 25.92 | 25.01 | 25.86 | 1M |
| 02 October 2026 | 24.96 | 25.46 | 24.87 | 25.23 | 939,600 |
| 01 October 2026 | 25.11 | 25.37 | 24.79 | 24.85 | 2M |
| 30 September 2026 | 24.83 | 25.49 | 24.80 | 25.19 | 980,500 |
| 29 September 2026 | 25.25 | 25.34 | 24.33 | 24.79 | 2M |
| 28 September 2026 | 25.47 | 25.96 | 25.40 | 25.52 | 1M |
| 25 September 2026 | 25.88 | 26.05 | 25.39 | 25.44 | 1M |
| 24 September 2026 | 25.66 | 26.21 | 25.25 | 25.97 | 1M |
| 23 September 2026 | 26.10 | 26.42 | 25.64 | 25.83 | 1M |
| 22 September 2026 | 26.96 | 27.15 | 26.16 | 26.24 | 882,000 |
| 21 September 2026 | 27.22 | 27.25 | 26.67 | 26.86 | 821,000 |
| 18 September 2026 | 27.01 | 27.30 | 26.95 | 27.13 | 3M |
| 17 September 2026 | 27.38 | 27.65 | 26.97 | 27.01 | 828,700 |
| 16 September 2026 | 27.63 | 27.92 | 27.15 | 27.38 | 864,500 |
| 15 September 2026 | 27.88 | 27.91 | 27.58 | 27.76 | 690,800 |
| 14 September 2026 | 27.69 | 27.98 | 27.42 | 27.85 | 1M |